300
Participants
Start Date
May 31, 2011
Primary Completion Date
December 31, 2012
Study Completion Date
March 31, 2013
Nexagon® Low Dose
Weekly, topical application of Nexagon® low dose used with compression dressings.
Nexagon® High Dose
Weekly, topical application of Nexagon® high dose used with compression dressings.
Nexagon® Vehicle
Weekly, topical application of Nexagon® Vehicle used with compression dressings.
WorthwhileClinical Trials, Johannesburg
Dr D. Lakha, Johannesburg
Awhinatina Health, Manukau
Sunninghill Hospital, Johannesburg
Witwatersrand University Medical School, Johannesburg
South Sydney Vascular Centre, Sydney
Randles Road Medical Centre, Durban
GCT Mercantile Clinical Trial Centre, Port Elizabeth
Boland Ethical Research Group, Cape Town
Josha Research, Bloemfontein
St Luke's - Roosevelt Hospital Center Department of Surgery, New York
Stonybrook Univeristy Medical Center, New York
Penn North Center For Advanced Wound Care, Erie
Penn North Center For Advanced Wound Care, Kittaning
Center For Advanced Wound Care, Wyomissing
Doctor's Research Network, South Miami
South Florida Wound Care Group, Tamarac
Northwestern University Feinberg School of Medicine, Chicago
Passavant Area Hospital, Jacksonville
St. John Wound Center, Tulsa
UT Southwestern Medical Center, Dallas
Saint Paul's Women's Center, Dallas
DRMC Wound Clinic, Saint Geroge
Associated Foot and Ankle Specialists, LLC, Phoenix
Aung Foot Health Clinics, Tucson
Southern Arizona Limb Salvage Alliance, Tucson
Advanced Foot & Ankle Center, Las Vegas
Diabetic Foot & Wound Treatment Center, El Centro
Advanced Foot Care and Clinical Research Center, Fresno
Bay Area Foot Care, Castro Valley
Oceana Country Foot and Ankle, Toms River
Heidelberg Repatriation Hospital, Melbourne
Dunedin Hospital, Dunedin
Unitas Hospital, Johannesburg
Lead Sponsor
OcuNexus Therapeutics, Inc.
INDUSTRY